The trademark application ZACLIPTA was filed by Johnson & Johnson, a U.S. corporation (the "Applicant"). The application was published for oppositions on October 17, 2021, and it was registered by office on January 24, 2022 without any oppositions.
The application was filed in Dutch (English was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on December 19, 2022.